A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy

Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of positive surgical margins in 200 sequential robotic assisted laparoscopic radical prostatectomy and 200 sequential open radical retropubic pr...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of urology Vol. 178; no. 6; p. 2385
Main Authors Smith, Jr, Joseph A, Chan, Robert C, Chang, Sam S, Herrell, S Duke, Clark, Peter E, Baumgartner, Roxy, Cookson, Michael S
Format Journal Article
LanguageEnglish
Published United States 01.12.2007
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of positive surgical margins in 200 sequential robotic assisted laparoscopic radical prostatectomy and 200 sequential open radical retropubic prostatectomy cases. From July 2002 until December 2006 a total of 1,747 patients underwent radical prostatectomy at our institution (robotic assisted laparoscopic radical prostatectomy in 1,238, radical retropubic prostatectomy in 509). From these we selected the last 200 consecutive radical retropubic prostatectomies and 200 robotic assisted laparoscopic radical prostatectomies performed before August 2006. Preoperative clinical characteristics including age, clinical stage, prostate specific antigen and Gleason score were evaluated. Postoperatively pathological specimens were assessed for specimen weight, Gleason score, tumor volume, pathological stage and margin status. The incidence and location of positive surgical margins were compared between robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy. Patients undergoing robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy had more favorable tumor characteristics including lower prostate specific antigen, clinical stage and Gleason score. No statistically significant differences were found between groups for prostate volume or tumor volume. However, tumor volume as a percentage of prostate volume was higher among radical retropubic prostatectomy compared to robotic assisted laparoscopic radical prostatectomy cases (17.7% vs 13%, p = 0.001). The overall incidence of positive surgical margins was significantly lower among the robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy cases (15% vs 35%, p <0.001). The incidence of positive surgical margins according to pathological stage for robotic assisted laparoscopic radical prostatectomy vs radical retropubic prostatectomy cases was 16 of 171 (9.4%) vs 33 of 137 (24.1%) for pT2 (p <0.001) and 14 of 28 (50%) vs 36 of 60 (60%) for pT3. In both groups the apex was the most common site of positive surgical margins with 52% in the robotic assisted laparoscopic radical prostatectomy group vs 37% in the radical retropubic prostatectomy group (p >0.05). In the hands of surgeons experienced in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy, there was a statistically significant lower positive margin rate for patients undergoing robotic assisted laparoscopic radical prostatectomy. The most common location of a positive surgical margin in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy cases was at the apex. Patients treated with radical retropubic prostatectomy had higher risk features which may have independently influenced these results. The method of pathological specimen analysis and reporting may account for the higher positive margin rates in both groups compared to some reports.
AbstractList Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of positive surgical margins in 200 sequential robotic assisted laparoscopic radical prostatectomy and 200 sequential open radical retropubic prostatectomy cases. From July 2002 until December 2006 a total of 1,747 patients underwent radical prostatectomy at our institution (robotic assisted laparoscopic radical prostatectomy in 1,238, radical retropubic prostatectomy in 509). From these we selected the last 200 consecutive radical retropubic prostatectomies and 200 robotic assisted laparoscopic radical prostatectomies performed before August 2006. Preoperative clinical characteristics including age, clinical stage, prostate specific antigen and Gleason score were evaluated. Postoperatively pathological specimens were assessed for specimen weight, Gleason score, tumor volume, pathological stage and margin status. The incidence and location of positive surgical margins were compared between robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy. Patients undergoing robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy had more favorable tumor characteristics including lower prostate specific antigen, clinical stage and Gleason score. No statistically significant differences were found between groups for prostate volume or tumor volume. However, tumor volume as a percentage of prostate volume was higher among radical retropubic prostatectomy compared to robotic assisted laparoscopic radical prostatectomy cases (17.7% vs 13%, p = 0.001). The overall incidence of positive surgical margins was significantly lower among the robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy cases (15% vs 35%, p <0.001). The incidence of positive surgical margins according to pathological stage for robotic assisted laparoscopic radical prostatectomy vs radical retropubic prostatectomy cases was 16 of 171 (9.4%) vs 33 of 137 (24.1%) for pT2 (p <0.001) and 14 of 28 (50%) vs 36 of 60 (60%) for pT3. In both groups the apex was the most common site of positive surgical margins with 52% in the robotic assisted laparoscopic radical prostatectomy group vs 37% in the radical retropubic prostatectomy group (p >0.05). In the hands of surgeons experienced in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy, there was a statistically significant lower positive margin rate for patients undergoing robotic assisted laparoscopic radical prostatectomy. The most common location of a positive surgical margin in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy cases was at the apex. Patients treated with radical retropubic prostatectomy had higher risk features which may have independently influenced these results. The method of pathological specimen analysis and reporting may account for the higher positive margin rates in both groups compared to some reports.
Author Chan, Robert C
Chang, Sam S
Herrell, S Duke
Cookson, Michael S
Baumgartner, Roxy
Clark, Peter E
Smith, Jr, Joseph A
Author_xml – sequence: 1
  givenname: Joseph A
  surname: Smith, Jr
  fullname: Smith, Jr, Joseph A
  organization: Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765, USA
– sequence: 2
  givenname: Robert C
  surname: Chan
  fullname: Chan, Robert C
– sequence: 3
  givenname: Sam S
  surname: Chang
  fullname: Chang, Sam S
– sequence: 4
  givenname: S Duke
  surname: Herrell
  fullname: Herrell, S Duke
– sequence: 5
  givenname: Peter E
  surname: Clark
  fullname: Clark, Peter E
– sequence: 6
  givenname: Roxy
  surname: Baumgartner
  fullname: Baumgartner, Roxy
– sequence: 7
  givenname: Michael S
  surname: Cookson
  fullname: Cookson, Michael S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17936849$$D View this record in MEDLINE/PubMed
BookMark eNp1kEtOwzAQhi0Eog-4AAvkCySM7SSOl1XFS6rEpvvKscfgqomj2EXqjTgmFoUlqxn9M98_jwW5HMKAhNwxKBmw5mFf7o9TKDmALKEtAdoLMmc1l4WQis_IIsY9AKtqya_JjEklmrZSc_K1oib0o558DAMNjqYPpH4w3uJgkOrB0kMwOvlzdQzRJ_-JNB6nd2_0gfY6J0PMDJ1CF5I3VMfoY8JM6mwcogljVidtf4AxK0knNCn0p58BYcQMY5rCeOz-67whV04fIt7-xiXZPj1u1y_F5u35db3aFKaGOhVSN07UwoBDY1FwBYqrTjHnoGlMpbVsrQXeCRDGVsqhEMiEq7BqpOgcX5L7s21epUe7GyefLzzt_j7GvwHdQnTv
CitedBy_id crossref_primary_10_1093_jjco_hyy092
crossref_primary_10_1111_j_1442_2042_2012_03193_x
crossref_primary_10_1111_j_1464_410X_2010_09941_x
crossref_primary_10_1007_s11701_010_0171_5
crossref_primary_10_1111_j_1464_410X_2009_08685_x
crossref_primary_10_1016_j_ucl_2009_11_008
crossref_primary_10_1007_s00345_014_1393_3
crossref_primary_10_1177_1756287210364207
crossref_primary_10_1053_j_seminoncol_2013_04_004
crossref_primary_10_2214_AJR_14_13280
crossref_primary_10_1016_j_acuro_2012_11_015
crossref_primary_10_1111_and_13533
crossref_primary_10_1155_2011_645030
crossref_primary_10_1016_j_uromx_2016_01_002
crossref_primary_10_1089_end_2012_0013
crossref_primary_10_19161_etd_1168102
crossref_primary_10_1111_j_1464_410X_2008_08084_2_x
crossref_primary_10_1007_s00345_013_1230_0
crossref_primary_10_1111_iju_12447
crossref_primary_10_1007_s11701_010_0200_4
crossref_primary_10_1002_jso_24109
crossref_primary_10_1089_end_2009_0121
crossref_primary_10_1007_s11701_009_0169_z
crossref_primary_10_1007_s11701_008_0082_x
crossref_primary_10_1007_s11934_011_0180_6
crossref_primary_10_3349_ymj_2009_50_2_177
crossref_primary_10_1089_end_2010_0349
crossref_primary_10_1016_j_eururo_2013_10_030
crossref_primary_10_1097_MOU_0b013e3282f517d6
crossref_primary_10_3390_cancers14030688
crossref_primary_10_1089_end_2010_0184
crossref_primary_10_1007_s11701_008_0122_6
crossref_primary_10_1111_j_1464_410X_2008_07607_x
crossref_primary_10_1007_s10147_022_02278_7
crossref_primary_10_5410_wjcu_v5_i1_24
crossref_primary_10_1007_s11701_011_0247_x
crossref_primary_10_1016_j_urolonc_2022_08_012
crossref_primary_10_1089_end_2011_0507
crossref_primary_10_1111_j_1464_410X_2009_09176_x
crossref_primary_10_3390_cancers13010106
crossref_primary_10_1016_j_juro_2012_09_169
crossref_primary_10_3349_ymj_2016_57_5_1165
crossref_primary_10_1371_journal_pone_0249991
crossref_primary_10_1111_j_1442_2042_2010_02546_x
crossref_primary_10_1016_j_eururo_2009_11_008
crossref_primary_10_18632_oncotarget_13332
crossref_primary_10_1016_j_urology_2009_09_085
crossref_primary_10_1038_aja_2008_10
crossref_primary_10_1016_j_urolonc_2011_03_003
crossref_primary_10_1016_j_urolonc_2016_03_021
crossref_primary_10_1007_s11934_008_0043_y
crossref_primary_10_1016_j_eursup_2010_02_009
crossref_primary_10_1038_aja_2008_11
crossref_primary_10_1111_bju_12509
crossref_primary_10_1016_j_juro_2014_05_124
crossref_primary_10_1016_j_urolonc_2011_07_013
crossref_primary_10_1007_s00120_008_1656_y
crossref_primary_10_1016_j_juro_2009_02_139
crossref_primary_10_1186_1748_717X_7_194
crossref_primary_10_1590_S1677_55382009000200002
crossref_primary_10_1016_j_eururo_2010_02_017
crossref_primary_10_1111_j_1464_410X_2011_10053_x
crossref_primary_10_1089_end_2008_0056
crossref_primary_10_1038_s41598_021_93860_y
crossref_primary_10_1089_end_2009_0144
crossref_primary_10_1016_j_eururo_2013_11_018
crossref_primary_10_1007_s00345_020_03298_6
crossref_primary_10_1155_2011_878323
crossref_primary_10_1016_j_eururo_2014_07_012
crossref_primary_10_1097_MOU_0b013e32834d5455
crossref_primary_10_1089_end_2017_0693
crossref_primary_10_1038_modpathol_2010_178
crossref_primary_10_1111_bju_12258
crossref_primary_10_1016_j_eururo_2011_11_053
crossref_primary_10_1007_s11701_011_0266_7
crossref_primary_10_1038_srep27419
crossref_primary_10_1007_s00345_009_0379_z
crossref_primary_10_1007_s11701_008_0121_7
crossref_primary_10_1111_j_1464_410X_2009_09158_x
crossref_primary_10_1007_s11701_011_0307_2
crossref_primary_10_1586_erp_10_46
crossref_primary_10_1016_j_juro_2011_04_079
crossref_primary_10_1016_j_juro_2016_01_105
crossref_primary_10_1089_end_2011_0336
crossref_primary_10_1016_j_urolonc_2009_07_021
crossref_primary_10_1016_j_acuroe_2012_11_019
crossref_primary_10_1111_j_1442_2042_2008_02232_x
crossref_primary_10_1016_j_ejso_2011_09_006
crossref_primary_10_1016_j_urology_2008_11_011
crossref_primary_10_15406_unoaj_2018_06_00221
crossref_primary_10_1590_S1677_5538_IBJU_2015_0385
crossref_primary_10_1016_j_humpath_2011_04_029
crossref_primary_10_1111_j_1464_410X_2009_08996_x
crossref_primary_10_1155_2013_768647
crossref_primary_10_1111_j_1464_410X_2007_07440_x
crossref_primary_10_1007_s00120_008_1657_x
crossref_primary_10_1016_j_juro_2009_11_039
crossref_primary_10_1016_j_aju_2011_12_001
crossref_primary_10_1016_j_eururo_2014_01_039
crossref_primary_10_1590_s1677_5538_ibju_2017_0702
crossref_primary_10_1111_bju_15133
crossref_primary_10_1111_j_1464_410X_2009_08419_x
crossref_primary_10_1016_j_ajur_2019_12_004
crossref_primary_10_1111_j_1442_2042_2009_02437_x
crossref_primary_10_1007_s11701_009_0162_6
crossref_primary_10_1089_end_2011_0569
crossref_primary_10_1089_end_2008_0398
crossref_primary_10_1007_s11701_012_0335_6
crossref_primary_10_1177_2051415813519628
crossref_primary_10_1007_s00261_011_9805_y
crossref_primary_10_1148_radiol_14140044
crossref_primary_10_1159_000366008
crossref_primary_10_1177_107327481502200305
crossref_primary_10_1007_s13193_016_0582_5
crossref_primary_10_1016_j_eururo_2010_01_040
crossref_primary_10_3346_jkms_2015_30_11_1631
crossref_primary_10_1016_j_urolonc_2009_03_031
crossref_primary_10_1136_jclinpath_2011_200533
crossref_primary_10_2478_jbcr_2019_0023
crossref_primary_10_1038_modpathol_2010_155
crossref_primary_10_1016_j_urolonc_2010_10_004
crossref_primary_10_1186_1471_2490_14_6
crossref_primary_10_1111_j_1365_2559_2011_04002_x
crossref_primary_10_1007_s10147_019_01587_8
crossref_primary_10_1053_j_ro_2015_08_004
crossref_primary_10_1007_s11701_009_0158_2
crossref_primary_10_1111_j_1464_410X_2010_09336_x
crossref_primary_10_1016_j_eururo_2009_01_036
crossref_primary_10_1111_j_1464_410X_2009_08895_x
crossref_primary_10_1111_j_1464_410X_2011_10529_x
crossref_primary_10_1155_2011_673021
crossref_primary_10_1001_jamanetworkopen_2020_1894
crossref_primary_10_1016_j_acuroe_2015_01_001
crossref_primary_10_1089_lap_2011_0388
crossref_primary_10_1007_s00432_022_04243_3
crossref_primary_10_1016_j_juro_2011_03_112
crossref_primary_10_1007_s00345_013_1149_5
crossref_primary_10_1111_j_1464_410X_2012_11503_x
crossref_primary_10_1016_S0976_0016_11_60185_3
crossref_primary_10_1016_j_juro_2009_11_017
crossref_primary_10_1089_end_2013_0393
crossref_primary_10_1007_s11255_012_0262_5
crossref_primary_10_1111_j_1464_410X_2010_10077_x
crossref_primary_10_1016_j_acuro_2013_07_011
crossref_primary_10_1016_j_acuroe_2013_11_011
crossref_primary_10_1111_iju_13281
crossref_primary_10_1002_jso_24040
crossref_primary_10_1111_iju_12070
crossref_primary_10_1007_s11701_011_0313_4
crossref_primary_10_1016_j_juro_2009_03_028
crossref_primary_10_1016_j_suronc_2009_02_009
crossref_primary_10_1016_j_acuro_2014_02_021
crossref_primary_10_1007_s00120_012_2881_y
crossref_primary_10_5980_jpnjurol_101_1
crossref_primary_10_1016_j_eururo_2017_11_035
crossref_primary_10_1016_j_juro_2015_03_009
crossref_primary_10_1590_S1677_5538_IBJU_2013_05_05
crossref_primary_10_1053_j_semdp_2011_10_001
crossref_primary_10_1016_j_juro_2008_10_022
crossref_primary_10_12954_PI_12001
crossref_primary_10_1007_s00345_008_0293_9
crossref_primary_10_1586_era_10_35
crossref_primary_10_1016_j_urolonc_2009_08_015
crossref_primary_10_32948_auo_2020_10_08
crossref_primary_10_4111_kju_2013_54_12_824
crossref_primary_10_1016_j_eururo_2012_08_059
crossref_primary_10_2217_cer_13_23
crossref_primary_10_1016_j_eururo_2010_10_026
crossref_primary_10_1200_EDBK_175666
crossref_primary_10_1007_s11701_021_01333_1
crossref_primary_10_1111_j_1464_410X_2010_09662_x
crossref_primary_10_1007_s11701_020_01179_z
crossref_primary_10_1016_j_ajur_2022_02_014
crossref_primary_10_1016_j_juro_2009_08_037
crossref_primary_10_1016_j_urology_2008_08_484
crossref_primary_10_1007_s11934_013_0327_8
crossref_primary_10_1016_j_maturitas_2009_12_011
crossref_primary_10_1016_j_juro_2015_08_092
crossref_primary_10_1007_s13629_011_0058_x
crossref_primary_10_1016_j_juro_2009_06_046
crossref_primary_10_1016_j_urolonc_2011_12_002
crossref_primary_10_1016_j_purol_2013_02_003
crossref_primary_10_1016_j_urology_2009_11_079
crossref_primary_10_1111_j_1464_410X_2010_09795_x
crossref_primary_10_1111_j_1464_410X_2011_10501_x
crossref_primary_10_1038_pcan_2009_17
crossref_primary_10_5301_RU_2013_10834
crossref_primary_10_1002_pros_23114
crossref_primary_10_1007_s13193_016_0594_1
crossref_primary_10_1586_era_11_85
crossref_primary_10_1089_end_2009_0212
crossref_primary_10_3390_medicines5020032
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1016/j.juro.2007.08.008
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3792
ExternalDocumentID 17936849
Genre Journal Article
Comparative Study
GroupedDBID ---
--K
.55
.GJ
.XZ
08P
0R~
123
1B1
1CY
354
3O-
4.4
457
4G.
4Q1
4Q2
4Q3
53G
5RE
5VS
7-5
AAAAV
AAEDT
AAEDW
AAGIX
AAHPQ
AAIQE
AAJCS
AAKAS
AALRI
AAMOA
AAQFI
AAQKA
AAQQT
AAQXK
AASCR
AASXQ
AAXUO
ABASU
ABCQX
ABDIG
ABJNI
ABLJU
ABMAC
ABOCM
ABPPZ
ABVCZ
ACGFS
ACILI
ACLDA
ACOAL
ACXJB
ADGGA
ADHPY
ADMUD
ADNKB
ADPAM
ADZCM
AEBDS
AEETU
AENEX
AFDTB
AFEXH
AFFNX
AFTRI
AFUWQ
AGHFR
AHOMT
AHQNM
AHRYX
AHVBC
AI.
AINUH
AITUG
AIZYK
AJIOK
AJNWD
AJZMW
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AMRAJ
ASGHL
ASPBG
AVWKF
AZFZN
BCGUY
BELOY
BYPQX
C45
C5W
CGR
CS3
CUY
CVF
DIWNM
DU5
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F5P
FCALG
FDB
FEDTE
FGOYB
GBLVA
GNXGY
GQDEL
HLJTE
HVGLF
HZ~
H~9
IH2
IHE
IKREB
IKYAY
IPNFZ
J5H
KMI
L7B
M41
MJL
MO0
N4W
NPM
NQ-
NTWIH
O9-
OAG
OAH
OB3
OBH
ODMTH
OGROG
OHH
OL1
OVD
OWU
OWV
OWW
OWY
OWZ
P2P
QTD
R2-
RIG
RLZ
ROL
RPZ
SEL
SES
SJN
SSZ
TEORI
TSPGW
UDS
UNMZH
UV1
VH1
VVN
WOW
X7M
XH2
XYM
YFH
YOC
ZCG
ZFV
ZGI
ZXP
ZY1
ZZMQN
ID FETCH-LOGICAL-c505t-7a6f353c0fecde3290929b91ff066c4aa78dd02b303cd49fe33e13f4e4673bf2
IngestDate Tue Oct 15 23:38:53 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c505t-7a6f353c0fecde3290929b91ff066c4aa78dd02b303cd49fe33e13f4e4673bf2
PMID 17936849
ParticipantIDs pubmed_primary_17936849
PublicationCentury 2000
PublicationDate 2007-12-01
PublicationDateYYYYMMDD 2007-12-01
PublicationDate_xml – month: 12
  year: 2007
  text: 2007-12-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of urology
PublicationTitleAlternate J Urol
PublicationYear 2007
References 17936808 - J Urol. 2007 Dec;178(6):2249
18823916 - J Urol. 2008 Nov;180(5):2257; author reply 2257
18499156 - J Urol. 2008 Jul;180(1):410-1; author reply 411
References_xml
SSID ssj0014572
Score 2.4271855
Snippet Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of...
SourceID pubmed
SourceType Index Database
StartPage 2385
SubjectTerms Adult
Aged
Aged, 80 and over
Blood Loss, Surgical - physiopathology
Cohort Studies
Follow-Up Studies
Humans
Laparoscopy - methods
Male
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Pain Measurement
Pain, Postoperative - physiopathology
Probability
Prostate-Specific Antigen - blood
Prostatectomy - instrumentation
Prostatectomy - methods
Prostatic Neoplasms - mortality
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
Retrospective Studies
Robotics
Survival Analysis
Treatment Outcome
Title A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy
URI https://www.ncbi.nlm.nih.gov/pubmed/17936849
Volume 178
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYKK632goB98JYPe6uC0jiNk2OFQBUSXOhK3JDt2Ae0bapsuwd-EX-I_8OM7dRJgRXLJapiN209X2fGn-dByE-hBnyghIFNTg4bFHCZo1yWKkpLsM5ccZ1JTBS-us7Gv9LL2-Ftr_fUilpaLuSpeng1r-QjUoV7IFfMkv0Pya4eCjfgNcgXriBhuL5LxiMfQu7bCFonErlz2yfUHgugqWp8Qhef9Vf3_yxrp--moka-2ea0VLKytVvhP4IMaP83WFGsdFnNscizcMc5c8wREXjuUE1d4SbsvtWv9QIbgcm3ZrY94JCLZr3gZd3h9VdEz2UdzicC34q5ECEePDC8ZyvaW0wDmTvWde2PVW76GIbSoTh4K1xEe7WcoCosunqb5y2AdrQwc22AXpgHx1Tcn97Dj_PlKzGUNm9PBhHPpxYwqLuy3FVU_ffoWsnuZmiDbPAcle81Ukj-aCsd8sRnb7lAw_Uvg3Vs_QPW9jrW55lsky0vJjpyyNshPT3bJZ-vfDjGV_I4ogGAtDIUAEhXAKSAD9oAEEcbANIGgNQDEN5DPQBpA0DaBiD1sKIdWNkPQADSAMDXZ34jk4vzydk48q0_IgUu-SLiIjNsyFRstCo1S4oY3HhZDIwBF1mlQvC8LONEggOmyrQwmjE9YCbVYPeZNMl3sjmrZnqP0NRoHsskMxwc5yKORZmBSSsLZgwssEj3yQ-3xHdzV97lrln8gzdHDsmXANMj8smAPtHH4Jwu5IkV9jN6x5lB
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comparison+of+the+incidence+and+location+of+positive+surgical+margins+in+robotic+assisted+laparoscopic+radical+prostatectomy+and+open+retropubic+radical+prostatectomy&rft.jtitle=The+Journal+of+urology&rft.au=Smith%2C+Jr%2C+Joseph+A&rft.au=Chan%2C+Robert+C&rft.au=Chang%2C+Sam+S&rft.au=Herrell%2C+S+Duke&rft.date=2007-12-01&rft.eissn=1527-3792&rft.volume=178&rft.issue=6&rft.spage=2385&rft_id=info:doi/10.1016%2Fj.juro.2007.08.008&rft_id=info%3Apmid%2F17936849&rft_id=info%3Apmid%2F17936849&rft.externalDocID=17936849